No Data
No Data
Prevention and correction in one, Angelalign (06699) children's cavity prevention invisible aligners are fully launched.
Angelalign (06699) announced that its innovative children's exclusive anti-caries invisible aligners will be fully launched in dental clinics nationwide.
[Brokerage Focus] HAITONG INT'L maintains a "Buy" rating on Angelalign (06699), highlighting the company's differentiated product portfolio and outstanding medical service advantages.
Jinwu Financial News | HAITONG INT'L Research Reports indicate that Times Angel (06699) will achieve a total of 0.359 million invisible corrective cases in 2024 (+46.7%). Among these, international cases reach 0.141 million (+326.4%), accounting for 39.1% of the total, further expanding overseas brand influence; domestic cases total 0.218 million (+3.2%), maintaining a leading position in the domestic market. Revenue is expected to reach 0.27 billion USD (+28.2%), with a gross margin of 62.6% (+0.2pp), sales expense ratio of 39.1% (+5.6pp), and management expense ratio of 17.2% (-1.8
Earnings Update: Angelalign Technology Inc. Beat Earnings And Now Analysts Have New Forecasts For This Year
Angelalign (06699) granted 0.073 million restricted share units.
Angelalign (06699) announced that in order to provide long-term incentives to key employees, on March 21, 2025,...
ANGELALIGN: GRANT OF RESTRICTED SHARE UNITS UNDERTHE POST-IPO RSU SCHEME; ANDCLARIFICATION IN RELATION TO THE ANNUAL RESULTSANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2024
Angelalign Technology's Attributable Profit Rises in 2024; Shares Fall 9%